Abstract
The genomics revolution has provided an overwhelming choice of potential drug targets for cancer therapy. Central to this revolution are approaches that identify target genes by changes in gene expression or through bioinformatic searching of DNA / protein databases for homologous sequences. An alternative to these approaches is functional cloning which selects gene products based on the ability of a given sequence to directly alter a cellular phenotype of interest. In an effort to discover new cancer therapeutic targets, bioinformatic searching and functional cloning were utilized to identify novel gene products implicated in various aspects of tumorigenesis. Using homology searches of DNA databases for novel death domain-encoding expressed sequence tags (ESTs), a new member of the TNF receptor family, DR6, was identified that regulated apoptosis in a variety of cell types and exhibited deregulated expression in tumor cells. Functional cloning of cDNAs from tumor cells with the capacity to induce morphological transformation, uncovered a unique oncogene, FGFR2-FRAG1, that resulted from a chromosomal rearrangemen t between a receptor tyrosine kinase, FGFR2, and a novel gene, FRAG1. This review focuses on these approaches as a means to identify potential targets for therapeutic intervention in cancer and the unique challenges each of these techniques face to link the identified gene products to a given biological effect or disease state.
Current Genomics
Title: Identifying and Validating Oncology Therapeutic Targets in the Post- Genomics Era
Volume: 4 Issue: 1
Author(s): Jian J. Lu and Matthew V. Lorenzi
Affiliation:
Abstract: The genomics revolution has provided an overwhelming choice of potential drug targets for cancer therapy. Central to this revolution are approaches that identify target genes by changes in gene expression or through bioinformatic searching of DNA / protein databases for homologous sequences. An alternative to these approaches is functional cloning which selects gene products based on the ability of a given sequence to directly alter a cellular phenotype of interest. In an effort to discover new cancer therapeutic targets, bioinformatic searching and functional cloning were utilized to identify novel gene products implicated in various aspects of tumorigenesis. Using homology searches of DNA databases for novel death domain-encoding expressed sequence tags (ESTs), a new member of the TNF receptor family, DR6, was identified that regulated apoptosis in a variety of cell types and exhibited deregulated expression in tumor cells. Functional cloning of cDNAs from tumor cells with the capacity to induce morphological transformation, uncovered a unique oncogene, FGFR2-FRAG1, that resulted from a chromosomal rearrangemen t between a receptor tyrosine kinase, FGFR2, and a novel gene, FRAG1. This review focuses on these approaches as a means to identify potential targets for therapeutic intervention in cancer and the unique challenges each of these techniques face to link the identified gene products to a given biological effect or disease state.
Export Options
About this article
Cite this article as:
Lu J. Jian and Lorenzi V. Matthew, Identifying and Validating Oncology Therapeutic Targets in the Post- Genomics Era, Current Genomics 2003; 4 (1) . https://dx.doi.org/10.2174/1389202033350119
DOI https://dx.doi.org/10.2174/1389202033350119 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Chemopreventive Agents Alters Global Gene Expression Pattern: Predicting their Mode of Action and Targets
Current Cancer Drug Targets 12-Lipoxygenase: A Potential Target for Novel Anti-Platelet Therapeutics
Cardiovascular & Hematological Agents in Medicinal Chemistry Development and Clinical Application of Peptide-Based Radiopharmaceuticals
Current Pharmaceutical Design Bladder Cancer: Innovative Approaches Beyond the Diagnosis
Current Medicinal Chemistry Role of α6β4 Integrin in Cell Motility, Invasion and Metastasis of Mammary Tumors
Current Protein & Peptide Science Advances in Electrospinning of Nanofibers and their Biomedical Applications
Current Tissue Engineering (Discontinued) Editorial [Hot Topic: Cancer Genetics (Guest Editor: Anirban Maitra)]
Current Molecular Medicine Inflammation, Microenvironment, and the Immune System in Cancer Progression
Current Pharmaceutical Design Oleamide Derivatives are Prototypical Anti-Metastasis Drugs that Act by Inhibiting Connexin 26
Current Drug Safety Role for Poly(ADP-ribose) Polymerase Activation in Diabetic Nephropathy, Neuropathy and Retinopathy
Current Vascular Pharmacology Pharmacological Effect of Berberine Chloride in Propyl Thiouracil Induced Thyroidal Dysfunction - A Time Bound Study in Female Rats
Recent Patents on Drug Delivery & Formulation Estrogenic Phenol and Catechol Metabolites of PCBs Modulate Catechol-Omethyltransferase Expression Via the Estrogen Receptor: Potential Contribution to Cancer Risk
Current Drug Metabolism The Anticancer Activity of the N-Terminal CARD-Like Domain of Arginine Deiminase (ADI) from Pseudomonas aeruginosa
Letters in Drug Design & Discovery Managing Skin Malignancies- How Family Doctors, Plastic Surgeons, and Dermatologists Can Help
Current Cancer Therapy Reviews Analysis of Taiwan Patents for the Medicinal Mushroom “Niu-Chang- Chih”
Recent Patents on Food, Nutrition & Agriculture Lymphoblastoid Cell Lines Models of Drug Response: Successes and Lessons from this Pharmacogenomic Model
Current Molecular Medicine Heavy Metals and Epigenetic Alterations in Brain Tumors
Current Genomics Altered Hyaluronan Biosynthesis and Cancer Progression: an Immunological Perspective
Mini-Reviews in Medicinal Chemistry Association of Viruses in the Development of Cardiovascular Diseases
Current Pharmaceutical Design Charge Deficient Analogues of the Natural Polyamines
Current Pharmaceutical Design